AMTEK (NYSE:AME) dropped slightly amid mild profit booking and the last known price was $47.44 per share. The price decreased by -0.88 points or -1.82% which made the investors to buy on weakness. For the latest trading session, the net money flow was recorded at $3.81 million. The total upticks were valued at $10.96 million and the total downticks aggregated to $7.15 million, thereby putting the up/down ratio at 1.53,. The shares have seen a change in the share price of -0.08% on a weekly basis.In a big block trade which occurred today, the total uptick value was $5.99 million and the total downtick value was $1.38, resulting in an up/down ratio of 4.34. The net money flow for the block trade was calculated to be $4.61 million.
Currently the company Insiders own 2% of AMTEK shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -50% . Institutional Investors own 88.83% of AMTEK shares. During last six month period, the net percent change held by insiders has seen a change of -17.21%. On the companys insider trading activities,The director of Ametek Inc/, Malone James R sold 1,350 shares at $47.83 on May 27, 2016. The Insider selling transaction had a total value worth of $64,571. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
AMTEK (NYSE:AME) stock ended Monday session in the red zone in a volatile trading. The stock closed down 1.06 points or 2.19% at $47.26 with 1,584,848 shares getting traded. Post opening the session at $48.09, the shares hit an intraday low of $47.21 and an intraday high of $48.27 and the price was in this range throughout the day. The company has a market cap of $11,031 million and the number of outstanding shares have been calculated to be 233,410,060 shares. The 52-week high of AMTEK (NYSE:AME) is $57.67 and the 52-week low is $42.82.
Many analysts have stated their opinion on the company shares. In a research note released to the investors, Atlantic Equities downgrades its rating on AMTEK (NYSE:AME).The analysts at the brokerage house have a current rating of Neutral on the shares. Earlier, the shares were rated a Overweight by the brokerage firm. The rating by the firm was issued on April 29, 2016.
AMETEK, Inc. (AMETEK) is a manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. AMETEK markets and sells its products through two groups: Electronic Instruments (EIG) and Electromechanical (EMG). The Companys EIG segment designs and manufactures advanced instruments for the process, aerospace, power and industrial markets. It offers process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor and factory automation industries. The Companys EMG segment offers electrical connectors and electronics packaging used in aerospace and defense, medical and industrial applications, as well as its advanced technical motor and motion control products, which are used in a range of medical devices, office and business equipment, factory automation, robotics and other applications.